Our Vision
Provide more effective and safer vaccines to fight infectious diseases important for animal and human health.
Pan Genome Systems Focus on livestock (cattle, camels, sheep, goats) and Poultry Health Products. We also help other strategic partners in testing their products.
What We Do
Pan Genome Systems develops and delivers novel, patent-protected vaccines and diagnostics directed to control Johne’s disease in Cattle, Avian Influenza and Avian Coronavirus (Infectious Bronchitis Virus) in Poultry. We also provide research services to help others in developing their own products after signing the appropriate agreements.
Pan Genome Systems' products and services are helpful to other researchers, farmers, technicians, veterinarians and veterinary labs.
We treat every customer as our partner. Our success is your success.
Pan Genome Systems' products are born of world-class science. Our core technology has been developed and honed over 15 years of laboratory research, and commercial development.
Our Product Promise
Safe
The safety of our products is paramount. We have carefully created products with both animals and farmers in mind, putting product safety first.
Simple
Our single-dose vaccines are easily administered on the farm and maximize protection while reducing workload for busy farmers.
Effective
Detailed studies, in the laboratory, in controlled conditions, and in the field, have proven the effectiveness of our products to reduce infections, reduce disease spread, and reduce side-effects.
Proven
Our products have been subject to the most rigorous of laboratory and field testing by world-leading scientists, industry experts, and real farmers over years of product testing and development.
Our People
Management Team
Board of Directors
Dr. Adel Talaat, Ph.D Chairman/CEO
Dr. Bill Checovich, Ph.D Director of Operations, Global Consumables Illumina Corporation
Board Member
Dr. Michael T. Collins, DVM, Ph.D, DACVM Board Member
News
Pan Genome Systems develops a protective vaccine against Johne’s disease in Cattle
A new study published in the journal “Microorganisms” shows that PGS’ live attenuated vaccine against Johne’s disease can induce a robust T cell immune response in a safe fashion and minimize fecal shedding when tested in cattle. This vaccine has been successfully tested in mice and goats previously. Abstract: Johne’s disease (JD) caused by Mycobacterium avium subsp. paratuberculosis (M.…
UW-Madison Spinoff Pursues COVID-19 Vaccine
University of Wisconsin (UW)–Madison houses an important lab where ongoing research led to an experimental animal vaccine to protect chickens from coronavirus. Upon the COVID-19 outbreak starting late last year, Adel Talaat, who runs a lab at the UW-Madison, recently leveraged the vaccine to advance a candidate for humans. Talaat commenced testing the vaccine on mice…
PGS develop a novel vaccine that is safe and effective to control paratuberculosis
See the following article for published in a premier nature group journal, Vaccines. A single dose polyanhydride-based nanovaccine against paratuberculosis infection. Thukral, A., K. Ross, C. Hansen, Y. Phanse, B. Narasimhan, H. Steinberg and A. M. Talaat (2020). npj Vaccines 5(1): 15. https://www.nature.com/articles/s41541-020-0164-y
PGS develops a novel protective vaccine against different strains of chicken Influenza
PGS used a propriety mosaic sequence of multiples isolates of highly pathogenic isolates of Avian Influenza to develop a protective vaccine with almost sterilizing immunity that can benefit poultry flocks. This vaccine targets both low and high pathogenicity isolates of Avian Influenza. See the details in the following article: Effective mosaic-based nanovaccines against avian influenza…
Patents:
Inventor: Adel M. Talaat, Bassam Abomoelak and Sarah K. Ward. Immunogenic Compositions Against Tuberculosis. US 8,367,055 B2. (Issued)
Inventor: Adel M. Talaat. Vaccine Candidates Against Johne’s Disease. US 8,758,77
(Issued)
Inventor: Adel M. Talaat. Global gene regulators (GGR) as vaccine candidates against paratuberculosis. US 10,544,389 (Issued)
Inventor: Adel M. Talaat. RNA Biomarkers for Early Diagnosis of Mycobacterial Infections. WARF: P130075US01 (Pending)
Inventor: Adel M. Talaat and Sekar Chandrasekar. WARFplex: A novel adjuvant for animal and human vaccines. WARF: P190189 (Pending).
Inventor: Adel M. Talaat and Brock Bakke. A universal vaccine against Infectious Bronchitis Virus, Avian Influenza, Newcastle Disease Virus and Infectious Bursal Disease. WARF: P190239 (Pending).